Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Blinatumomab> ?p ?o. }
Showing items 1 to 64 of
64
with 100 items per page.
- Blinatumomab abstract "Blinatumomab (MT103) is a drug that has anti-cancer properties. It belongs to a new class of constructed monoclonal antibodies, bi-specific T-cell engagers (BiTEs), that exert action selectively and direct the human immune system to act against tumor cells. Blinatumomab specifically targets the CD19 antigen present on B cells.The drug was developed by a German-American company Micromet, Inc. in cooperation with Lonza.".
- Blinatumomab atcPrefix "none".
- Blinatumomab casNumber "853426-35-4".
- Blinatumomab fdaUniiCode "4FR53SIF3A".
- Blinatumomab thumbnail BiTE_antibody_en.svg?width=300.
- Blinatumomab wikiPageExternalLink results?term=blinatumomab.
- Blinatumomab wikiPageID "18875843".
- Blinatumomab wikiPageRevisionID "603602328".
- Blinatumomab atcPrefix "none".
- Blinatumomab c "2367".
- Blinatumomab casNumber "853426".
- Blinatumomab chemspiderid "NA".
- Blinatumomab h "3577".
- Blinatumomab hasPhotoCollection Blinatumomab.
- Blinatumomab mabType "BiTE".
- Blinatumomab molecularWeight "54.1".
- Blinatumomab n "649".
- Blinatumomab o "772".
- Blinatumomab s "19".
- Blinatumomab source "o".
- Blinatumomab target CD19.
- Blinatumomab target CD3_(immunology).
- Blinatumomab type "mab".
- Blinatumomab unii "4".
- Blinatumomab verifiedfields "changed".
- Blinatumomab verifiedrevid "459980828".
- Blinatumomab subject Category:Monoclonal_antibodies_for_tumors.
- Blinatumomab type Abstraction100002137.
- Blinatumomab type Antibody115027189.
- Blinatumomab type Chemical114806838.
- Blinatumomab type Compound114818238.
- Blinatumomab type Macromolecule114944888.
- Blinatumomab type Material114580897.
- Blinatumomab type Matter100020827.
- Blinatumomab type Molecule114682133.
- Blinatumomab type MonoclonalAntibodiesForTumors.
- Blinatumomab type MonoclonalAntibody115029781.
- Blinatumomab type OrganicCompound114727670.
- Blinatumomab type Part113809207.
- Blinatumomab type PhysicalEntity100001930.
- Blinatumomab type Protein114728724.
- Blinatumomab type Relation100031921.
- Blinatumomab type Substance100019613.
- Blinatumomab type Thing100002452.
- Blinatumomab type Unit109465459.
- Blinatumomab type Drug.
- Blinatumomab type DrugProduct.
- Blinatumomab type FunctionalSubstance.
- Blinatumomab comment "Blinatumomab (MT103) is a drug that has anti-cancer properties. It belongs to a new class of constructed monoclonal antibodies, bi-specific T-cell engagers (BiTEs), that exert action selectively and direct the human immune system to act against tumor cells. Blinatumomab specifically targets the CD19 antigen present on B cells.The drug was developed by a German-American company Micromet, Inc. in cooperation with Lonza.".
- Blinatumomab label "Blinatumomab".
- Blinatumomab label "Blinatumomab".
- Blinatumomab label "Blinatumomab".
- Blinatumomab label "Blinatumomab".
- Blinatumomab label "بليناتوموماب".
- Blinatumomab sameAs Blinatumomab.
- Blinatumomab sameAs Blinatumomab.
- Blinatumomab sameAs Blinatumomab.
- Blinatumomab sameAs m.04gm0f3.
- Blinatumomab sameAs Q410189.
- Blinatumomab sameAs Q410189.
- Blinatumomab sameAs Blinatumomab.
- Blinatumomab wasDerivedFrom Blinatumomab?oldid=603602328.
- Blinatumomab depiction BiTE_antibody_en.svg.
- Blinatumomab isPrimaryTopicOf Blinatumomab.